People with more severe cases of psoriasis may be at increased risk of uncontrolled hypertension.
Omron Healthcare announced the launch of a new line of blood pressure monitors.
The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with Xolair.
The Food and Drug Administration (FDA) has approved Lutonix DCB (Lutonix 035 Drug Coated Balloon) Percutaneous Transluminal Angioplasty (PTA) Catheter.
After surgery for prostate cancer, elevated levels of cholesterol and triglycerides may be linked with greater risk of the cancer's return, new research suggests.
Research on cannabis use conducted over the past 20 years have provided insight on adverse effects such as an increased risk of psychosis and cardiovascular events, but many of the findings do not account for confounders or are unable to establish a causal relationship.
Reductions in heart events and death last for many years after stopping therapy in patients with type 2 diabetes that take antihypertensives, Australian researchers have found.
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) may increase risk of venous thromboembolism (VTE).